SDZXF (Sandoz Group AG) Research & Development: $1,050 Mil (TTM As of Dec. 2025)


SDZXF Sandoz Group AG SDZXF
18 GF Score
Price $89.55
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Research & Development?

Sandoz Group AG SDZXF 18 Research & Development is $1,050 Mil as of Dec. 2025. GuruFocus rates SDZXF with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sandoz Group AG's Research & Development for the six months ended in Dec. 2025 was $546 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $1,050 Mil.

Sandoz Group AG  (OTCPK:SDZXF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sandoz Group AG Research & Development Related Terms

Sandoz Group AG Research & Development Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Research & Development Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
833.00 926.00 932.00 1,050.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 479.00 489.00 443.00 504.00 546.00
SDZXF
18GF Score
Sandoz Group AG SDZXF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1,050 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1,050 Mil mean?
Sandoz Group AG (SDZXF) has a Research & Development of $1,050 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Research & Development too high?
Sandoz Group AG's current Research & Development is $1,050 Mil. Overall, Sandoz Group AG has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Research & Development compare to ZTS and UTHR?
Sandoz Group AG's Research & Development of $1,050 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Research & Development is $1,050 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (SDZXF) has a current Research & Development of $1,050 Mil. The current Research & Development is $1,050 Mil. Sandoz Group AG's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sandoz Group AG (SDZXF), the current Research & Development is $1,050 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
18GF Score

Get the complete analysis for SDZXF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.55
Price